EP Patent

EP2043637B1 — Methods and medicaments for administration of ibuprofen

Assigned to Horizon Therapeutics USA Inc · Expires 2012-01-04 · 14y expired

What this patent protects

A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided, in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine is administered three times per day.

USPTO Abstract

A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided, in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine is administered three times per day.

Drugs covered by this patent

Patent Metadata

Patent number
EP2043637B1
Jurisdiction
EP
Classification
—
Expires
2012-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Horizon Therapeutics USA Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.